{"id":1063237,"date":"2010-05-02T08:16:53","date_gmt":"2010-05-02T08:16:53","guid":{"rendered":"http:\/\/www.longevitymedicine.tv\/csc-news-links-2010-05-01\/"},"modified":"2024-08-17T20:28:03","modified_gmt":"2024-08-18T00:28:03","slug":"csc-news-links-2010-05-01","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/stem-cell-therapy\/csc-news-links-2010-05-01.php","title":{"rendered":"CSC news links 2010-05-01"},"content":{"rendered":"<p>For links to recent news items, visit these [<a title=\"Twitter \/ jimtill\" href=\"http:\/\/twitter.com\/jimtill\" target=\"_blank\" rel=\"noopener\">Twitter<\/a>] or [<a title=\"Jim Till's FriendFeed page\" href=\"http:\/\/friendfeed.com\/tillje\" target=\"_blank\" rel=\"noopener\">FriendFeed<\/a>] pages. Examples of two news items that have received attention:? <\/p><ul><li><a title=\"Distinct expression levels and patterns of stem cell marker, aldehyde dehydrogenase isoform 1 (ALDH1), in human epithelial cancers\" href=\"http:\/\/dx.doi.org\/10.1371\/journal.pone.0010277\" target=\"_blank\" rel=\"noopener\">Distinct expression levels and patterns of stem cell marker, aldehyde dehydrogenase isoform 1 (ALDH1), in human epithelial cancers<\/a> by Shan Deng and 15 co-authors, including <a title=\"George Coukos\" href=\"http:\/\/www.med.upenn.edu\/apps\/faculty\/index.php\/g5455356\/p19864\" target=\"_blank\" rel=\"noopener\">George Coukos<\/a> and <a title=\"Lin Zhang\" href=\"http:\/\/www.med.upenn.edu\/apps\/faculty\/index.php\/g5455356\/p7157\" target=\"_blank\" rel=\"noopener\">Lin Zhang<\/a>, <em>PLoS ONE<\/em>, 2010(Apr 21); 5(4): e10277 [<a title=\"Connbotea bookmark\" href=\"http:\/\/www.connotea.org\/article\/24cc90ed56fb6fef6f469f3693a27620\" target=\"_blank\" rel=\"noopener\">Connbotea bookmark<\/a>][<a title=\"PubMed Citation\" href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20422001\" target=\"_blank\" rel=\"noopener\">PubMed Citation<\/a>][OA <a title=\"full text\" href=\"http:\/\/www.plosone.org\/article\/info%3Adoi%2F10.1371%2Fjournal.pone.0010277\" target=\"_blank\" rel=\"noopener\">full text<\/a>]. Last sentence of the abstract:<br><blockquote><p>As a novel cancer stem cell marker, ALDH1 can be used for tumors whose corresponding normal tissues express ALDH1 in relatively restricted or limited levels such as breast, lung, ovarian or colon cancer.<\/p><\/blockquote><\/li><li><a title=\"AACR: Are Cancer Stem Cells Vulnerable to Trastuzumab?\" href=\"http:\/\/www.medpagetoday.com\/MeetingCoverage\/AACR\/19625\" target=\"_blank\" rel=\"noopener\">AACR: Are Cancer Stem Cells Vulnerable to Trastuzumab?<\/a> By <a title=\"Ed Susman\" href=\"http:\/\/www.linkedin.com\/pub\/edward-susman\/4\/729\/175\" target=\"_blank\" rel=\"noopener\">Ed  Susman<\/a>, <em>MedPage Today<\/em> (Apr 19) [<a title=\"FriendFeed entry\" href=\"http:\/\/ff.im\/jFsxX\" target=\"_blank\" rel=\"noopener\">FriendFeed entry<\/a>][<a title=\"AACR10 abstract\" href=\"http:\/\/www.abstractsonline.com\/Plan\/ViewAbstract.aspx?sKey=9eb08e9a-49fe-4d6c-8463-22e8f0bd35b9&amp;cKey=d416b499-3e04-4aaa-836f-0569c07b4ba6&amp;mKey=%7B0591FA3B-AFEF-49D2-8E65-55F41EE8117E%7D\" target=\"_blank\" rel=\"noopener\">AACR10 abstract<\/a>]. Excerpt:<br><blockquote><p>Mathematical modeling suggests that even in women whose breast cancer does not overexpress the HER-2 gene, treatment with trastuzumab (Herceptin) in the adjuvant setting could wipe out cancer stem cells, researchers reported here.<\/p><\/blockquote><p><\/p><\/li><p><\/p><\/ul><div><img loading=\"lazy\" decoding=\"async\" width=\"1\" height=\"1\" src=\"http:\/\/www.longevitymedicine.tv\/wp-content\/plugins\/wp-o-matic\/cache\/98ddc_35997458635844014-8338934877456068886?l=cancerstemcellnews.blogspot.com\" alt=\"\" style=\"padding-left:10px; padding-right: 10px;\"><\/div>","protected":false},"excerpt":{"rendered":"<p>For links to recent news items, visit these [Twitter] or [FriendFeed] pages. Examples of two news items that have received attention:? Distinct expression levels and patterns of stem cell marker, aldehyde dehydrogenase isoform 1 (ALDH1), in human epithelial cancers by &hellip; <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/stem-cell-therapy\/csc-news-links-2010-05-01.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":64,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[25,1246878],"tags":[],"class_list":["post-1063237","post","type-post","status-publish","format-standard","hentry","category-stem-cell-therapy","category-stem-cells"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1063237"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/64"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=1063237"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1063237\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=1063237"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=1063237"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=1063237"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}